Drug
MoviPrep clinical trials
- studies test it
- 22
- open now
- 0
- in phase 3
- 7
- first study started
- 2001
How studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
22 studies that test it; most in 2002 (2)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 4
- Phase 3
- 7
- Phase 4
- 5
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 12
Norgine (9) · Korea University Anam Hospital (2) · Yale University (1) · Unidade Local de Saúde do Alto Ave, EPE (1) · Assistance Publique - Hôpitaux de Paris (1) · Parc de Salut Mar (1) · Takeda (1) · University of Nottingham (1)
Often tested with
Tested in the same studies.
Picosulfate sodium (2) · Magnesium citrate (2) · Polyethylene glycol 3350 (2) · Polyethylene Glycols (2) · MAAT013 (1) · Ipilimumab (1) · Nivolumab (1) · Normacol (1)
Studies
Open first, then newest update. How each study uses MoviPrep is read from its arms, and is right about nine times in ten.
Testing it · 22
- MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing ColonoscopyCompletedPhase 4Yale UniversityNCT05054036Written as MoviPrep
- PEG-Asc Vs. SPMC for Bowel Preparation in Capsule-based ProceduresCompletedNot applicableUnidade Local de Saúde do Alto Ave, EPENCT07206329Written as Polyethylene Glycol plus Ascorbic Acid (PEG-Asc)
- Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOmaCompletedPhase 2Assistance Publique - Hôpitaux de ParisNCT04988841Written as MoviPrep
- A Monocentric Study to Investigate a New Low Dose Oral Gut Cleansing SolutionCompletedPhase 2NorgineNCT06597903Written as NRL994
- Preparation Regimens to Improve Capsule Endoscopy Visualization and Diagnostic YieldStatus unknownNot applicableCentro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.NCT05140057Written as Moviprep
- The Affect of Low-Volume Bowel Preparation for Hospitalized Patients ColonoscopiesTerminatedNot applicableMayo ClinicNCT01978509Written as Moderate volume prep (Moviprep)
- The Use of Osmotic Laxatives Versus Macrogol for Bowel Preparation in Patients Undergoing ColonoscopyStatus unknownNot applicableRussian Society of Colorectal SurgeonsNCT04225793Written as MoviPrep
- Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic PatientsCompletedPhase 3Parc de Salut MarNCT02297399Written as PEG-ascorbate 2L
- Effect of Simethicone on Bowel Preparation for ColonoscopyCompletedPhase 3Korea University Anam HospitalNCT02548403Written as PEG-Asc
- A Multi-centre Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Solution (MOVIPREP®) Versus a Hyperosmotic and Stimulant Combined Low Volume Bowel Preparation (Sodium Picosulfate and Magnesium Citrate)CompletedPhase 4NorgineNCT01689792Written as MOVIPREP
- Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening ColonoscopyCompletedPhase 2NorgineNCT01714466Written as MOVIPREP
- A Randomized Prospective Trial Comparing Low-volume Bowel Preparation MethodsCompletedPhase 3Korea University Anam HospitalNCT02250196Written as PEG-Asc
- Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel PreparationCompletedPhase 3TakedaNCT01732692Written as MOVIPREP
- Mode of Action of MoviprepCompletedPhase 4University of NottinghamNCT01622972Written as Polyethyleneglycol
- Incidence of Hyponatremia in PEG-SD Compared to PEG-ELSCompletedNot applicableThomas Jefferson UniversityNCT01299779Written as PEG-ELS
- Scintigraphic Assessment Following Klean-Prep® or Moviprep®CompletedPhase 1NorgineNCT00896246Written as Moviprep®
- Moviprep® Versus Fleet Phospho-Soda® (Golden Standard): A Study That Compared Two Laxatives on Patients Undergoing Colo-Rectal Cleansing Prior to an Abdominal OperationCompletedPhase 4University Hospital, GhentNCT00618930Written as Moviprep®
- Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor ScreeningCompletedPhase 3NorgineNCT00427089Written as Macrogol 3350 Na sulphate NaCl KCl Ascorbic Acid Na Ascorbate
- MOVIPREP® Versus NaP Pivotal Phase III StudyCompletedPhase 3NorgineNCT00322062Written as macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate
- A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard SolutionCompletedPhase 3NorgineNCT00389233Written as Macrogol3350 NA sulphate NACl KCl ascorbic acid NA ascorbate
See all 22 studies that test MoviPrep →
Given in every arm · 2 — MoviPrep is usual care beside what is tested
As the comparator · 8 — what is tested is compared with MoviPrep
- Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of LifeCompletedNot applicableRadboud University Medical CenterNCT05242562Written as Moviprep
- Colon Cleansing Efficacy With 1L vs. 2L vs. 4L-PEG for Colonoscopy Among InpatientsStatus unknownPhase 4University of BolognaNCT04708366Written as MoviPrep
- Safety and Efficacy Study of an Edible Colonoscopy PreparationCompletedPhase 2Sebela Pharmaceuticals Development LLCNCT03332485Written as MoviPrep®
- Safety and Tolerability Study of an Edible Colon PreparationCompletedPhase 2ColonaryConcepts LLCNCT02402270Written as MoviPrep® (PEG 3350)
- A Comparison of 5 Low Volume Bowel PreparationsCompletedPhase 4Gastroenterology Services, Ltd.NCT01719653Written as MoviPrep
- Safety and Efficacy of CDFR0612 and CDFR0613 for Bowel Cleansing Before ColonoscopyCompletedPhase 3CTC Bio, Inc.NCT02304523Written as Coolprep Powder
- Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy SubjectsCompletedPhase 1NorgineNCT01834742Written as Moviprep
- Evaluation of a Mixed Bowel Prep (2L PEG + Bisacodyl) Versus PEG With AscorbateCompletedPhase 4Promefarm S.r.l.NCT01509131Written as 2L PEG-ASC